One end-to-end platform with connected intelligence across the entire drug-safety lifecycle. Built AI-native from the ground up, not a layer bolted onto legacy systems.
"AI That Thinks With You, Not Just For You."
Reimagining drug development with connected intelligence.
The pharmaceutical industry stands at a pivotal crossroads, pressed to break free from prolonged discovery cycles and fragmented, disconnected data. At TheragenX, we envision a transformative future where AI doesn't just automate tasks; it accelerates science itself.
"AI That Thinks With You, Not Just For You."
Eight AI-native modules on one connected data layer. Adopt what you need today; add the rest as you scale.
Six ways TheragenX breaks from legacy, monolithic safety systems, built AI-native from the ground up.
A modular rollout that scales from local to global operations with no heavy IT lift.
Integrate your data sources, gateways and existing systems in days.
Set triage rules, workflows and role-based access to your SOPs.
Automated validation gives you an inspection-ready evidence trail.
Run global operations with real-time intelligence from day one.
Compliance is embedded from the ground up, with automated audit trails and alignment to global standards, not bolted on at the end.
Security, data protection and regulatory compliance are engineered into the platform, validated against the standards that govern modern drug safety, not bolted on after the fact.
TheragenX accepted into NVIDIA Inception to advance AI-driven safety
Through NVIDIA's accelerated computing and AI expertise, we will further strengthen our ability to train, optimize, and deploy high-performance models across case intake, literature monitoring, signal detection, aggregate report authoring, and regulatory analytics.
See how TheragenX unifies your drug-safety operations on one AI-native platform.